Tackling Infections in Intensive care unit setting
DOI:
https://doi.org/10.66166/cjaim.2.1.4Keywords:
icu, mdro, infectionsAbstract
Infections within the intensive care unit (ICU) continue to be a major contributor to morbidity and mortality throughout Europe. Critically ill patients, oftentimes presenting with organ failure, having frequent interactions with invasive medical devices, and by receiving multiple antimicrobial agents are particularly susceptible to infections. Having knowledge of pathogen-specific epidemiology in ICUs across Europe and their antimicrobial resistance patterns is of utmost importance to choosing the right empirical therapy. Challenge posed by multidrug-resistant organisms, especially Gram-negative bacteria, is easier to tackle with infection prevention strategies, antimicrobial stewardship initiatives, and collaborative multidisciplinary care in place within the ICU setting.
References
1. Vincent JL. International Study of the Prevalence and Outcomes of Infection in Intensive Care Units. JAMA. 2009 Dec 2;302(21):2323. doi:10.1001/jama.2009.1754
2. Munro C, Zilberberg MD, Shorr AF. Bloodstream Infection in the Intensive Care Unit: Evolving Epidemiology and Microbiology. Antibiotics. 2024 Jan 26;13(2):123. doi:10.3390/antibiotics13020123
3. Vincent JL, Sakr Y, Singer M, Martin-Loeches I, Machado FR, Marshall JC, et al. Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017. JAMA. 2020 Apr 21;323(15):1478. doi:10.1001/jama.2020.2717
4. European Centre for Disease Prevention and Control. Healthcare-associated infections acquired in intensive care units – annual epidemiological report for 2021. Stockholm: ECDC; 2023. Available from: https://www.ecdc.europa.eu/en/publications-data/healthcare-associated-infections-acquired-intensive-care-units-annual.
5. European Centre for Disease Prevention and Control. Antimicrobial resistance in the EU/EEA (EARS-Net) – annual epidemiological report 2024. Stockholm: ECDC; 2025. Available from: https://www.ecdc.europa.eu/en/publications-data/antimicrobial-resistance-eueea-ears-net-annual-epidemiological-report-2024.
6. European Centre for Disease Prevention and Control. Surveillance of antimicrobial resistance in Europe 2022. Stockholm: ECDC; 2023. Available from: https://www.ecdc.europa.eu/en/publications-data/surveillance-antimicrobial-resistance-europe-2022-data.
7. Koulenti D, Tsigou E, Rello J. Nosocomial pneumonia in 27 ICUs in Europe: perspectives from the EU-VAP/CAP study. Eur J Clin Microbiol Infect Dis. 2017 Nov;36(11):1999–2006. doi:10.1007/s10096-016-2703-z
8. Torres A, Niederman MS, Chastre J, Ewig S, Fernandez-Vandellos P, Hanberger H, et al. International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociación Latinoamericana del Tórax (ALAT). Eur Respir J. 2017 Sep;50(3):1700582. doi:10.1183/13993003.00582-2017
9. Laupland KB, Zygun DA, Davies HD, Church DL, Louie TJ, Doig CJ. Population-based assessment of intensive care unit-acquired bloodstream infections in adults: Incidence, risk factors, and associated mortality rate: Crit Care Med. 2002 Nov;30(11):2462–7. doi:10.1097/00003246-200211000-00010
10. Tabah A, Bassetti M, Kollef MH, Zahar JR, Paiva JA, Timsit JF, et al. Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP). Intensive Care Med. 2020 Feb;46(2):245–65. doi:10.1007/s00134-019-05866-w
11. Tabah A, Buetti N, Staiquly Q, Ruckly S, Akova M, Aslan AT, et al. Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study. Intensive Care Med. 2023 Feb;49(2):178–90. doi:10.1007/s00134-022-06944-2
12. Pronovost P, Needham D, Berenholtz S, Sinopoli D, Chu H, Cosgrove S, et al. An Intervention to Decrease Catheter-Related Bloodstream Infections in the ICU. N Engl J Med. 2006 Dec 28;355(26):2725–32. doi:10.1056/NEJMoa061115
13. Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, et al. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2016 Feb 15;62(4):e1–50. doi:10.1093/cid/civ933
14. Napolitano LM. Intra-abdominal Infections. Semin Respir Crit Care Med. 2022 Feb;43(01):010–27. doi:10.1055/s-0041-1741053
15. for the EPIC II Investigators, De Waele J, Lipman J, Sakr Y, Marshall JC, Vanhems P, et al. Abdominal infections in the intensive care unit: characteristics, treatment and determinants of outcome. BMC Infect Dis. 2014 Dec;14(1):420. doi:10.1186/1471-2334-14-420
16. Montravers P, Lepape A, Dubreuil L, Gauzit R, Pean Y, Benchimol D, et al. Clinical and microbiological profiles of community-acquired and nosocomial intra-abdominal infections: results of the French prospective, observational EBIIA study. J Antimicrob Chemother. 2009 Feb 17;63(4):785–94. doi:10.1093/jac/dkp005
17. Hooton TM, Bradley SF, Cardenas DD, Colgan R, Geerlings SE, Rice JC, et al. Diagnosis, Prevention, and Treatment of Catheter-Associated Urinary Tract Infection in Adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis. 2010 Mar 1;50(5):625–63. doi:10.1086/650482
18. Conway Morris A, Smielewska A. Viral infections in critical care: a narrative review. Anaesthesia. 2023 May;78(5):626–35. doi:10.1111/anae.15946
19. Choi SH, Hong SB, Ko GB, Lee Y, Park HJ, Park SY, et al. Viral Infection in Patients with Severe Pneumonia Requiring Intensive Care Unit Admission. Am J Respir Crit Care Med. 2012 Aug 15;186(4):325–32. doi:10.1164/rccm.201112-2240OC
20. Shah NS, Greenberg JA, McNulty MC, Gregg KS, Riddell J, Mangino JE, et al. Bacterial and viral co-infections complicating severe influenza: Incidence and impact among 507 U.S. patients, 2013–14. J Clin Virol. 2016 Jul;80:12–9. doi:10.1016/j.jcv.2016.04.008
21. Giacobbe DR, Battaglini D, Ball L, Brunetti I, Bruzzone B, Codda G, et al. Bloodstream infections in critically ill patients with COVID‐19. Eur J Clin Invest. 2020 Oct;50(10):e13319. doi:10.1111/eci.13319
22. Zhang J, Lan P, Yi J, Yang C, Gong X, Ge H, et al. Secondary bloodstream infection in critically ill patients with COVID-19. J Int Med Res. 2021 Dec;49(12):03000605211062783. doi:10.1177/03000605211062783
23. Morris AC, Hay AW, Swann DG, Everingham K, McCulloch C, McNulty J, et al. Reducing ventilator-associated pneumonia in intensive care: Impact of implementing a care bundle*. Crit Care Med. 2011 Oct;39(10):2218–24. doi:10.1097/CCM.0b013e3182227d52
24. Barlam TF, Cosgrove SE, Abbo LM, MacDougall C, Schuetz AN, Septimus EJ, et al. Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016 May 15;62(10):e51–77. doi:10.1093/cid/ciw118
Downloads
Published
Data Availability Statement
Data not made available as it is a review article.
Issue
Section
License
Copyright (c) 2026 Željko Đurić, Mia Slade-Vitković, Iva Ćosić, Marko Siroglavić (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
